(Q30357046)

20 June 2017

Protein-structure-based prediction of animal model suitability for pharmacodynamic studies of subtype-selective estrogens. (English)

1 reference

protein structure prediction

20 June 2017

0 references

1 reference

Luisella Toschi

1

1 reference

20 June 2017

Jochen Hilbig

2

1 reference

20 June 2017

Tim Wintermantel

3

1 reference

20 June 2017

Adelheid Engelhaupt

4

1 reference

20 June 2017

Alexander Walter

5

1 reference

20 June 2017

Karl-Heinrich Fritzemeier

6

1 reference

20 June 2017

Alexander Hillisch

7

1 reference

20 June 2017

1 November 2006

1 reference

20 June 2017

1 reference

20 June 2017

1

1 reference

20 June 2017

11

1 reference

20 June 2017

1237-1248

1 reference

Estrogen receptors alpha and beta: two receptors of a kind?

20 June 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

Mechanisms of estrogen action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Role of estrogen receptor beta in estrogen action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Structure-based design of estrogen receptor-beta selective ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Cloning of bovine estrogen receptor beta (ERbeta): expression of novel deleted isoforms in reproductive tissues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

A single amino acid that determines the sensitivity of progesterone receptors to RU486.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

RU486 is not an antiprogestin in the hamster

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Utility of homology models in the drug discovery process.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600183

7 January 2021

Identifiers

DOI

10.1002/CMDC.200600183

1 reference

20 June 2017

1 reference